Categories: NewsPharmaceutical

IDBS is proud to announce the renewal of its ISO 9001 and ISO 27001 certificates

WOKING, England, Sept. 3, 2024 /PRNewswire/ — IDBS, a provider of cloud software for BioPharma companies, is pleased to announce that its ISO 9001 and ISO 27001 certifications have just completed their major reassessment cycle and will be valid for a further three years. Our independent auditors, DNV, observed that IDBS’ processes were operating to a consistently high standard, and commented on IDBS’ open culture of integrity and communication, and commitment to continuous improvement. IDBS has maintained ISO 9001 certification continuously since 2004 and ISO 27001 continuously since 2016.

IDBS is recognized as one of the BioPharma industry’s leading providers of software for compliant workflows, data management and insights from R&D through manufacturing. The company recently published its updated Quality Policy to underline its commitment to quality and excellence and the certification renewal is further testament to its dedication to providing high-quality solutions that meet and exceed customers’ expectations.

Further information regarding IDBS’ Quality Policy and other certifications can be found at idbs.com/about/quality-and-compliance/

About IDBS

IDBS helps BioPharmaceutical organizations accelerate the discovery, development and manufacturing of the next generation of life-changing therapies that advance human health worldwide. From the lab through manufacturing, IDBS leverages its 30+ years of experience working with a diverse list of customers – including 18 of the top 20 global BioPharma companies – and deep expertise in scientific informatics and process data management to tackle today’s most complex challenges.

Known for its signature IDBS E-WorkBook product, IDBS has extended solutions across the entire value chain for BioPharma Lifecycle Management (BPLM). Built on analytics-centric and cloud technology, IDBS Polar and PIMS platforms leverage a digital data backbone to drive faster and smarter decisions in drug development and manufacturing across the supply chain.

Learn more at idbs.com.

MEDIA ENQUIRIES
 e | mediaenquiries@idbs.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/idbs-is-proud-to-announce-the-renewal-of-its-iso-9001-and-iso-27001-certificates-302235165.html

SOURCE IDBS

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

17 minutes ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

3 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

3 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

3 hours ago